"Voluto e progettato dallo stesso don Gnocchi, il Centro ha progressivamente ampliato e diversificato negli anni la propria offerta. Oggi all'interno della struttura - riconosciuta IRCCS-Istituto di Ricovero e Cura a Carattere Scientifico - convivono una pluralità di servizi alla persona che rispondono a un ventaglio di esigenze molto diverse: sanitarie, educative, formative e assistenziali. Il tutto con un denominatore comune: la qualità dei servizi e la costante attenzione ai bisogni dei pazienti. Il Centro afferisce al Dipartimento di Cura e Riabilitazione delle Gravi Cerebrolesioni Acquisite (GCA), che coinvolge i reparti di assistenza operativi anche in altri Centri della Fondazione."

During the past decade, IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 2 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi" #1 collaborator was "Catholic University of the Sacred Heart" with 3 trials as a collaborator, "Campus Bio-Medico University" with 1 trials as a collaborator, "Centre Hospitalier Universitaire de Besancon" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator and "Ferrer Internacional S.A." with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi" are "Multiple Sclerosis" (3 trials), "Alzheimer's Disease" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Amyotrophic Lateral Sclerosis" (1 trials) and "Basal Ganglia Diseases" (1 trials). Many other conditions were trialed in "IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi" in a lesser frequency.

Most popular intervention types in "IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi" are "Other" (7 trials), "Drug" (4 trials), "Behavioral" (2 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Crenezumab" (2 trials), "Placebo" (2 trials), "Cardiovascular Polypill" (1 trials), "Compressed Medical Air" (1 trials) and "Conventional Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".